Philips (NYSE: PHG) today announced a final agreement on a consent decree with the FDA and U.S. Dept. of Justice (DOJ).
A U.S. federal court has officially ordered Philips to restrict the production and sale of its CPAP and BiPAP ventilators for ...
Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea ...
Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep ...
Subsidiaries of Philips, Philips Holding USA and Philips Respironics, agreed with the Justice Department and FDA's consent decree. The company also agreed with the recall remediation plan, which ...
Philips said it reached a final agreement with the U.S. Justice Department and Food and Drug Administration on terms of a settlement related its Respironics ventilators, and backed its medium-term ...
Federal Court Enters Consent Decree Against Philips Respironics Following Recall of Certain Sleep Therapy Machines ...
Philips (NYSE:PHG) on Wednesday reported that it has reached a final agreement with the U.S. Justice Department and Food and Drug Administration on a consent decree related to its Respironics ...
Philips said the costs of the consent decree led to a provision of 363 million euros in the fourth quarter of 2023, and were ...
, opens new tab announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, which has already cost the company over 360 million euros ...